你即將離開本站

並前往https://www.takeda.com/newsroom/newsreleases/2020/takeda-announces-u.s.-fda-breakthrough-therapy-designation-for-mobocertinib-tak-788-for-the-treatment-of-nsclc-patients-with-egfr-exon-20-insertion-mutations/

Takeda Announces U.S. FDA Breakthrough Therapy ...

... target EGFR and human EGFR 2 (HER2) exon 20 insertion mutations. ... Treatment of NSCLC Patients with EGFR Exon 20 Insertion Mutations.

確定！ 回上一頁

查詢 「Insertion mutation」的人也找了：

  1. insertion mutation中文
    2.
  2. Inversion mutation
    3.
  3. Structural mutation
    4.
  4. Gene mutation
    5.
  5. DNA mutation
    6.
  6. Nonsense mutation
    7.
  7. Insertion mutation
    8.
  8. Silent mutation
    9.